We may earn if you use our links. details
FORECASTEDNationwide

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregna

Plain-language brief

What this opportunity funds

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC), intends to renew and publish a Notice of Funding Opportunity (NOFO) to solicit applications to promote translational and clinical research in pregnant women, lactating women, infants, children, and adolescents to: (1) advance precision medicine through the development, testing, and implementation of novel tools, models, and other technologies; (2) discover and develop novel therapeutics or enhance the usage of existing drugs for safer and more effective medications; (3) enhance patient-provider communications about drug effectiveness and safety risks; and, (4) optimize the dissemination, implementation, sustainment, and scale-up of evidence-based interventions to these patient populations. The overall goal is to improve safe and effective precision therapeutics during pregnancy, lactation, and across childhood. Applications are not being solicited at this time.

Eligibility at a glance

Eligible applicants
For profit organizations other than small businesses, Small businesses, State governments, Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, City or township governments, Independent school districts, Native American tribal governments (Federally recognized), Special district governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, County governments, Others (see text field entitled "Additional Information on Eligibility" for clarification), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Eligible locations
Eligible applicants across the United States
Eligible activities
Health
Matching requirement
Not specified
Registration
SAM.gov, Grants.gov

Application process

  1. Read the complete official notice and confirm every eligibility rule.
  2. Complete required registrations early; federal registrations can take time.
  3. Build the budget, work plan, evidence, and attachments requested by the sponsor.
  4. Submit through the official portal and retain the confirmation.

Change history

No material changes have been recorded since this opportunity entered the hub.

Related opportunities

OPENNationwide

Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support the SenNet Data Coordination and Integration Center (SenNet DCIC) as a core component of Stage 2 of the NIH Common Fund Cellular Senescence Network (SenNet). The DCIC will enable timely, high-quality submission, harmonization, in

Award
Amount not specified
Deadline
Nov 23, 2026
Intermediary grantState governmentsIntermediary / support
✓ source verifiedVerified Oct 10, 2026
OPENNationwide

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support SenNet Discovery and Validation Centers (SenNet DVCs) as a core component of Stage 2 of the NIH Common Fund Cellular Senescence Network (SenNet). Building on Stage 1 resources, DVCs will define, refine, and validate tissue- and d

Award
Amount not specified
Deadline
Nov 23, 2026
Intermediary grantIndependent school districtsIntermediary / support
✓ source verifiedVerified Oct 10, 2026
OPENNationwide

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit the development of innovative senescence technologies (SenTecs), or the adaptation of existing technologies focused on identification, characterization and understanding the biological consequences of senescent cell (SnC) heterog

Award
Amount not specified
Deadline
Nov 23, 2026
Intermediary grantNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationIntermediary / support
✓ source verifiedVerified Oct 10, 2026